Skip to main content

Published locations for Migraine: Suboptimal first-dose responders may benefit from a second dose of eptinezumab

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Migraine: Suboptimal first-dose responders may benefit from a second dose of eptinezumab

User login

  • Reset your password
  • /content/migraine-suboptimal-first-dose-responders-may-benefit-second-dose-eptinezumab
  • /migraine-icymi/article/254827/headache-migraine/migraine-suboptimal-first-dose-responders-may